SCHEMBL14619505

SCHEMBL14619505

CCn1ccc2c(Cl)ncc(C(=O)N3CCCC3)c21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ HPGD P15428 3/20 0.40
▸ USP2 O75604 1/20 0.40
▸ CNR1 P21554 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ PDE4B Q07343 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ LMNA P02545 3/20 0.37
▸ TP53 P04637 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ NMT1 P30419 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3990376 0.84 CYP3A4 (0.51) SMN1; SMN2HPGDUSP2CNR1CYP2C19
SCHEMBL3988996 0.82 CYP3A4 (0.50) HPGDUSP2CNR1CYP2C19CYP3A4
SCHEMBL3988800 0.78 KMT2A (0.44) ALDH1A1SMN1; SMN2HPGDUSP2GAA
SCHEMBL3987827 0.73 CNR1 (0.64) ALDH1A1SMN1; SMN2HPGDCNR1CYP2C19
SCHEMBL12697375 0.72 TSHR (0.51) ALDH1A1SMN1; SMN2HPGDUSP2CNR1
SCHEMBL3989645 0.72 CNR2 (0.48) CNR1CYP2C19CYP3A4CYP2D6CYP2C9
SCHEMBL3989648 0.72 CNR1 (0.48) ALDH1A1HPGDUSP2CNR1CYP2C19
SCHEMBL3992803 0.70 CNR2 (0.79) ALDH1A1SMN1; SMN2HPGDCNR1CYP2C19
SCHEMBL12697435 0.70 CNR2 (0.48) ALDH1A1HPGDCNR1CNR2LMNA
Hydrochloric Acid SCHEMBL3993464 0.70 CNR2 (0.78) ALDH1A1SMN1; SMN2HPGDCNR1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007017264-A2 PYRROLOPYRIDINEDERIVATIVES AS MODULATORS OF THE CANNABINOID RECEPTOR FOR THE TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS GLAXO GROUP LIMITED (GB) 2007-02-15 — — WO disclosed
Send feedback